Seqens Seqens

X

Find Radio Compass News for Altiazem

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
94
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 120MG
  • TABLET;ORAL - 30MG
  • TABLET;ORAL - 60MG
  • TABLET;ORAL - 90MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 120MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 180MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 240MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 300MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 360MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE, EXTENDED RELEASE;ORAL - 120MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 180MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 240MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 300MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 360MG
  • CAPSULE, EXTENDED RELEASE;ORAL - 420MG
  • TABLET, EXTENDED RELEASE;ORAL - 120MG
  • TABLET, EXTENDED RELEASE;ORAL - 180MG
  • TABLET, EXTENDED RELEASE;ORAL - 240MG
  • TABLET, EXTENDED RELEASE;ORAL - 300MG
  • TABLET, EXTENDED RELEASE;ORAL - 360MG
  • TABLET, EXTENDED RELEASE;ORAL - 420MG

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-recalls-6528-bottles-of-blood-pressure-drug-in-us/articleshow/109287094.cms

ECONOMICTIMES
15 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-10-2024-2074.pdf

FDA
10 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2024-41763.pdf

FDA
03 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-31-2023-56013.pdf

FDA
31 May 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216327

FDA
06 Apr 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216552

FDA
29 Mar 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf

FDA
08 Mar 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216439

FDA
07 Mar 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-recalls-over-34k-bottles-of-generic-drug-in-us-due-to-manufacturing-issues/articleshow/97819610.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
11 Feb 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-8-2023-40474.pdf

FDA
08 Feb 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216521

FDA
23 Sep 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-10-2022-1660649426.pdf

FDA
10 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216304

FDA
08 Aug 2022

http://www.pharmabiz.com/NewsDetails.aspx?aid=136288&sid=2

PHARMABIZ
22 Mar 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208783

FDA
14 Jun 2019

https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf

FDA
20 Feb 2019

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-19-2018-1537361296.pdf

FDA
19 Sep 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205231

FDA
06 Sep 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-29-2018-1535509071.pdf

FDA
29 Aug 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf

FDA
11 Jul 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209766

FDA
01 Jun 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-2-2018-1525237297.pdf

FDA
02 May 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf

FDA
01 Nov 2017

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-for-blood-pressure-drug/articleshow/60083383.cms

ECONOMIC TIMES
16 Aug 2017

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf

FDA
16 Aug 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206534

FDA
09 Aug 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203023

FDA
09 Jun 2017

http://www.pharma-excipients.ch/2016/05/06/formulation-development-and-characterization-of-floating-beads-of-diltiazem-hydrochloride/

PHARMA-EXCIPIENTS
06 May 2016

http://www.pharma-excipients.ch/2016/02/18/formulation-and-development-of-ternary-hybrid-matrix-tablets-of-diltiazem-hydrochloride/

PHARMA-EXCIPIENTS
17 Feb 2016
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY